62.88
Ptc Therapeutics Inc (PTCT) 最新ニュース
Aug Levels: What is PTC Therapeutics Incs P E ratio telling us2025 Market WrapUp & Weekly Setup with ROI Potential - khodrobank.com
Short Squeeze: Will PTC Therapeutics Inc. benefit from government policyPortfolio Growth Summary & Smart Swing Trading Alerts - khodrobank.com
Will PTC Therapeutics Inc benefit from government policyMarket Volume Report & Low Risk Entry Point Tips - khodrobank.com
Gastroparesis Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Vanda Pharma, Dr. Falk Pharma GmbH, Alfasigma S.p.A., PTC Therapeutics, CinDome Pharma - The Globe and Mail
Ellsworth Advisors LLC Purchases Shares of 11,529 PTC Therapeutics, Inc. $PTCT - MarketBeat
Harbor Capital Advisors Inc. Grows Stock Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
Jobs Data: Will PTC Therapeutics Inc. benefit from geopolitical trendsInflation Watch & Step-by-Step Trade Execution Guides - خودرو بانک
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $3.07 Million Stake in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Director Emma Reeve Sells 15,705 Shares - MarketBeat
Using data filters to optimize entry into PTC Therapeutics Inc.Layoff News & Safe Entry Point Alerts - newser.com
Intech Investment Management LLC Buys 15,167 Shares of PTC Therapeutics, Inc. $PTCT - Defense World
PTC Therapeutics, Inc. $PTCT Shares Acquired by Acadian Asset Management LLC - Defense World
PTC Therapeutics, Inc. $PTCT Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Director Sells 12,000 Shares of Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Sets New 12-Month HighTime to Buy? - MarketBeat
Market Moves: Is PTC Therapeutics Inc. a stock for growth or value investorsJuly 2025 Recap & AI Based Buy and Sell Signals - خودرو بانک
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) VP Sells 24,585 Shares of Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) VP Mark Elliott Boulding Sells 22,664 Shares - MarketBeat
Death Cross: Will Heidrick & Struggles International Inc. announce a stock splitWeekly Market Report & Daily Stock Trend Watchlist - خودرو بانک
Recap Report: Is PTC Therapeutics Inc. stock a good dividend stockJuly 2025 Volume & Daily Risk Controlled Trade Plans - khodrobank.com
Bond Watch: What is PTC Therapeutics Incs valuation compared to sectorJuly 2025 PreEarnings & Precise Buy Zone Tips - khodrobank.com
Bayforest Capital Ltd Makes New Investment in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Insider Sells $2,268,262.00 in Stock - MarketBeat
Multi factor analysis applied to PTC Therapeutics Inc.July 2025 Pullbacks & Free Growth Oriented Trading Recommendations - newser.com
AQR Capital Management LLC Grows Stake in PTC Therapeutics, Inc. $PTCT - MarketBeat
Can PTC Therapeutics' (PTCT) New PKU Partnership Reveal Its Long-Term Rare Disease Strategy? - Sahm
Can PTC Therapeutics Inc. stock continue upward trendJuly 2025 Trends & Smart Money Movement Alerts - baoquankhu1.vn
Ptc Therapeutics stock hits 52-week high at 61.17 USD - Investing.com
PTC Therapeutics, Inc. $PTCT Shares Acquired by Parkman Healthcare Partners LLC - MarketBeat
Insider Sell: David Southwell Sells 12,000 Shares of PTC Therape - GuruFocus
PTC Therapeutics, Inc. (PTCT) Launches SUFIANCE for PKU - Insider Monkey
Adage Capital Partners GP L.L.C. Has $30.32 Million Holdings in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Insider Sell Alert: Eric Pauwels Sells 39,850 Shares of PTC Ther - GuruFocus
How sensitive is PTC Therapeutics Inc. to inflationJuly 2025 Recap & AI Based Buy and Sell Signals - Lancaster City Council
Bank of America Securities Keeps Their Buy Rating on PTC Therapeutics (PTCT) - The Globe and Mail
Canada Pension Plan Investment Board Raises Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Given Overweight Rating at Cantor Fitzgerald - MarketBeat
PTC Therapeutics at Morgan Stanley Conference: Strategic Insights and Updates - Investing.com Canada
PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment - Benzinga
BofA Securities Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $76 - 富途牛牛
Can PTC Therapeutics Inc. Overcome Bearish Sentiment2025 Short Interest & Technical Entry and Exit Tips - beatles.ru
Volume Surge May Signal Institutional Interest in PTC Therapeutics Inc.Trade Ideas & AI Enhanced Trade Execution Alerts - beatles.ru
PTC Therapeutics, Inc.'s (NASDAQ:PTCT) Shares Bounce 26% But Its Business Still Trails The Industry - simplywall.st
PTC Therapeutics (NASDAQ:PTCT) Director Sells $83,600.05 in Stock - MarketBeat
大文字化:
|
ボリューム (24 時間):